AC Immune SA ACIU
- semorinemab — Alzheimer's Disease Phase 2
- PI-2620 — Alzheimer's Disease Phase 3
- PI-2620 — Progressive Supranuclear Palsy Phase 3
Tau (1 companies · 3 programs)
Companies with an active program directed at Tau.
Companies with an active program directed at Tau.